Wealth Enhancement Advisory Services, LLC Neogenomics Inc Transaction History
Wealth Enhancement Advisory Services, LLC
- $55.6 Billion
- Q2 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 14,908 shares of NEO stock, worth $95,709. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,908Holding current value
$95,709% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NEO
# of Institutions
284Shares Held
127MCall Options Held
942KPut Options Held
172K-
Black Rock Inc. New York, NY19.7MShares$126 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.3MShares$91.5 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny6.72MShares$43.1 Million0.04% of portfolio
-
First Light Asset Management, LLC Edina, MN6.04MShares$38.8 Million7.36% of portfolio
-
Janus Henderson Group PLC London, X05.74MShares$36.9 Million0.03% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $808M
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...